- M&A Activity
Marsh McLennan’s (NYSE: MMC) subsidiary Oliver Wyman has finalized its purchase of Avascent, a management consulting firm supporting clients across defense, aerospace and government sectors, as part of efforts to form a combined entity with experience in deal and post-transaction work. The deal was first announced in October and Oliver Wyman said ...









